i
This Document Has Been Replaced By: Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccine administration errors and deviations
Superseded
This Document Has Been Replaced By: Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccine administration errors and deviations
Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccination strategies
-
August 9, 2022
Details:
-
Corporate Authors:
-
Description:Two vaccines may be used for the prevention of monkeypox disease:
• JYNNEOS vaccine is used for the prevention of smallpox and monkeypox disease among people determined to be at high risk for infection.
• ACAM2000 vaccine is approved for immunization against smallpox disease for people determined to be at high risk for infection. It has been made available for use against monkeypox in the current outbreak.
-
Content Notes:Vaccines -- Vaccination Strategies -- Table 1. Vaccination Strategies Used in the 2022 U.S. Monkeypox Outbreak -- Planning Considerations for Health Departments and Providers -- Health Equity -- Table of Contents -- Resources .
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: